Property:Inclusion criteria
This is a property of type Text.
H
Hejazi et al. (2016): Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study +
Patients referred to local curative radiotherapy with external beam radiotherapy (EBRT), in combination with hormone ablation; Adenocarcinoma of the prostate must be histologically confirmed on biopsy; life expectancy greater than 5 years; no metastatic disease detected during physical examination, standard radiography, bone scan, and magnetic resonance spectroscopy (MRS); no prior hormone therapy, radiotherapy or systemic treatment for prostate cancer and no other malignancy +
Henning et al. (2015): Randomized Clinical Trial of Brewed Green and Black Tea in Men With Prostate Cancer Prior to Prostatectomy +
40–70 years old; diagnosis of clinically localized prostate adenocarcinoma; were scheduled to undergo radical prostatectomy at least three weeks after study entry +
Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy +
Women with a history of stage I to III breast cancer, scheduled to undergo adjuvant taxane-based chemotherapy with one of the following standard regimens were included: paclitaxel 80 mg/m<sup>2</sup> once per week for 12 cycles, paclitaxel 175 mg/m<sup>2</sup> once every 2 weeks for four cycles, paclitaxel 175 mg/m<sup>2</sup> once every 2 weeks for six cycles, docetaxel 75 mg/m<sup>2</sup> once every 3 weeks for four cycles, or docetaxel 75 mg/m<sup>2</sup> once every 3 weeks for six cycles; Zubrod performance status of 0 to 2 +
Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine +
Women with a history of stage I to III breast cancer, scheduled to undergo adjuvant taxane-based chemotherapy with one of the following standard regimens were included: paclitaxel 80 mg/m<sup>2</sup> once per week for 12 cycles, paclitaxel 175 mg/m<sup>2</sup> once every 2 weeks for four cycles, paclitaxel 175 mg/m<sup>2</sup> once every 2 weeks for six cycles, docetaxel 75 mg/m<sup>2</sup> once every 3 weeks for four cycles, or docetaxel 75 mg/m<sup>2</sup> once every 3 weeks for six cycles; Zubrod performance status of 0 to 2 +
Hodgson et al. (2012): Reflexology versus Swedish Massage to Reduce Physiologic Stress and Pain and Improve Mood in Nursing Home Residents with Cancer: A Pilot Trial. +
Residents of the nursing home for at least 6 months, aged 75 or over, diagnosed with a solid tumor (lung, prostate,colorectal, breast) in the last 5 years, completed cancertreatments, and capable of giving informed consent, or had an acceptable surrogate capable of giving consenton the subjects behalf. +
Hoopfer et al. (2015): Three-arm randomized phase III trial: Quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy +
>18 years; nonmetastatic breast cancer; previous mastectomy or segmental resection; agreement to comply with the study protocol; signed informed consent +
Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics +
Subjects (18 years or older) presenting with confirmed stage IV colorectal cancer and hepatic metastases, who had not received therapeutic intervention for their cancer within 6 weeks of study commencement and had a life expectancy of >3 months, were recruited into the study. All patients were due to undergo resection of liver metastases. Participants had to be physically capable of complying with the protocol and had a normal ECG and no history of HIV or hepatitis B/C. +
I
Inglis et al. (2020): Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT +
A confirmed diagnosis of prostate cancer (stage I-IV) with no bone metastases; being within six months of starting androgen deprivation therapy (ADT) with an additional six more months planned; suboptimal vitamin D levels (<32 ng/ml); total serum calcium ≤10.5 mg/dl; no contraindications for fitness testing and 5) ≥60 years old +
Iovino et al. (2018): High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation +
Patients affected by Multiple Myeloma (MM) eligible to auto-hematopoietic stem cell transplantation (HSCT) +
J
Jacot et al. (2016): Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study +
Female patients with histologically confirmed primary early-stage breast cancer, treated in the last 12 months with adjuvant or neoadjuvant chemotherapy, and with an ECOG performance status of <2,
vitamin D deficiency +
Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial +
Patients with Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia, undergoing allogenic Hematopoietic Stem Cell Transplantation, all patients had adequate cardiac, pulmonary, renal, and hepatic function as determined by the institutional protocol
+ baseline indicates a mild selenium deficiency +
Jatoi et al. (2002): Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study +
Adult patients (≥18 years of age) with histologic evidence of an incurable malignancy other than brain, breast, ovarian, or endometrial cancer; estimated life expectancy of ≥3 months; Eastern Cooperative Oncology Group performance status of 0 to 2, as judged by their primary oncologist; self-reported weight loss of at least 5 pounds (2.3 kg) during the preceding 2 months and/or a physician-estimated caloric intake of less than 20 calories/kg of body weight per day; believe, that loss of appetite or loss of weight was an ongoing problem +
Jeon et al. (2016): Effect of intravenous high dose Vitamin C on postoperative pain and morphine use after laparoscopic colectomy: A randomized controlled trial +
Colon cancer patients aged 20 to 75 years, scheduled for elective laparoscopic colectomy
under general anesthesia +
Johansson et al. (2021): Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial +
Aged 75 years or younger with recent resected stage II cutaneous malignant melanoma; Hematopoietic, hepatic, and renal functionality within normal ranges +
Johnson et al. (2010): Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain +
Adult male or female patients, who had been using strong opioids for at least one week to relieve pain associated with incurable malignancy; pain severity score of 4 or above on a 0-10 Numerical Rating Scale (NRS) on both days of the two-day baseline period +
Jyothirmayi et al. (1996): Efficacy of Vitamin A in the Prevention of Locoregional Recurrence and Second Primaries in Head and Neck Cancer +
- Patients with HNC, who revealed complete clinical regression of lesions on follow-up after therapy
- Either radical radiotherapy or surgery or both during the earlier half of 1991
- No clinical evidence of disease, normal liver and kidney function +
K
Kadhim et al. (2021): Effect of Ginger Tea on Chemotherapy-Induced Nausea and Vomiting among Patients Attending the Oncology Teaching Hospital, Baghdad 2020 +
? +
Karp et al. (2012): Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 +
36 months from complete resection of histologically proven stage IA (pT1N0) or stage IB (pT2N0) NSCLC (carcinoid tumors were excluded); pathologic stage N0 confirmed by sampling at least one mediastinal lymph node at resection; chest x-ray or computed tomography scan ≤ 8 weeks before registration without sign of new or recurrent lung cancer; no concurrent cancers or any other prior cancer history within the past 5 years, except localized nonmelanoma skin cancer; no synchronous lesions (lung + nonlung) or metastasis, even if resectable; no history of greater than one lung cancer primary tumor at any time; normal hepatic function (total bilirubin and Aspartat-Aminotransferase or Alanin-Aminotransferase ≤ institutional upper limit of normal); laboratory values (incl. Complete Blood Count) obtained within 8 weeks before registration; and Eastern Cooperative Oncology Group performance status of 0 or 1.
Patients with stage IA Non-Small Cell Lung Cancer should not have received any therapy other than surgery. Patients with stage IB Non-Small Cell Lung Cancer were allowed to have received other primary therapy (chemotherapy, radiotherapy, or biologic therapy) provided this was completed at least 6 months before study registration and all treatment-related symptoms had subsided before study registration.
Supplements were defined as any nonfood compound taken by mouth or injection to provide dietary factors. Supplements containing ≥ 70 µg of selenium taken regularly (≥ three times per week for ≥ 4 consecutive weeks during the prior year) were required to be discontinued ≥ 1 month before registration. Supplements containing ≤ 70 µg of selenium were continued throughout study participation. Supplements not containing selenium were either discontinued ≥ 2 weeks before study entry or continued throughout study participation. +
Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer +
Patients with one-sided lymphatic oedema after axillary dissection due to mammary cancer, stage I to II; age ≥30 and ≤80 years; written, signed informed consent obtained +
Keshavarzi et al. (2019): The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer +
Being married, having stage 1 or 2 breast cancer based on the surgery stage, age below 50, receiving tamoxifen, not undergoing chemotherapy or radiotherapy during the study, a normal Pap smear during the last 3 years, no proven malignancies in other parts of the body, being sexually active during the study, meeting at least one of the criteria set in the genitourinary atrophy self-assessment, vaginal pH ≥ 5 according to Chollet et al. study at the time of the study, and a Vaginal Maturation Index (VMI) ≤52 according to Speroff’s study +